X0407 4 2023-05-18 0001398659 Genpact LTD G 0001408239 Tyagarajan N. V. C/O GENPACT LLC 521 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10175 true true President and CEO true Common Shares 2023-05-18 4 M 0 50000 19.35 A 855509 D Common Shares 2023-05-18 4 S 0 50000 37.946 D 805509 D Common Shares 2023-05-19 4 M 0 50000 19.35 A 855509 D Common Shares 2023-05-19 4 S 0 50000 38.4861 D 805509 D Common Shares 10000 I By Trust Employee Stock Option (Right to Buy) 19.35 2023-05-18 4 M 0 50000 0 D 2023-05-30 Common Shares 50000 50000 D Employee Stock Option (Right to Buy) 19.35 2023-05-19 4 M 0 50000 0 D 2023-05-30 Common Shares 50000 0 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $37.69 to $38.222. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $38.07 to $38.98. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein. The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. /s/ Thomas D. Scholtes, as Attorney-in-fact for N.V. Tyagarajan 2023-05-22